Checkpoint inhibitors are a class of drugs that help to unleash the immune system to recognize and attack cancer cells by blocking proteins that suppress immune responses. They have revolutionized cancer treatment, particularly in melanoma and lung cancer, by significantly improving survival rates in some patients.